Peri-operative platelet function testing: The potential for reducing ischaemic and bleeding risks

Keyphrases

• Operative 100%
• Peri 100%
• Bleeding Risk 100%
• Platelet Function 100%
• Event Occurrence 100%
• Platelet Function Tests 100%
• Ischemic Risk 100%
• Coronary Artery Bypass Grafting 66%
• Platelet Reactivity 66%
• Ischemic Events 66%
• High Risk 33%
• Bleeding 33%
• Prospective Clinical Trial 33%
• Translational Research 33%
• Absence of Evidence 33%
• Acute Coronary Syndrome 33%
• Platelet Inhibition 33%
• Large-scale Clinical Trial 33%
• Timing of Surgery 33%
• Platelet Activation 33%
• Blood Products 33%
• Dual Antiplatelet Therapy 33%
• Clopidogrel Therapy 33%
• Percutaneous Coronary Intervention 33%
• Clinical Validity 33%
• Threshold Level 33%
• Bleeding Events 33%
• P2Y12 Receptor 33%
• Atherothrombotic Event 33%
• High On-treatment Platelet Reactivity 33%
• Ex Vivo Studies 33%

Medicine and Dentistry

• Thrombocyte Function 100%
• Platelet Reactivity 75%
• Clinical Trial 50%
• Coronary Artery Bypass Graft 50%
• Epileptic Absence 25%
• Translational Research 25%
• Bleeding 25%
• Receptor 25%
• Ex Vivo 25%
• Platelet 25%
• Blood Product 25%
• Acute Coronary Syndrome 25%
• Antiplatelet 25%
• Percutaneous Coronary Intervention 25%
• Clopidogrel 25%
• Thrombocyte Activation 25%